An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants

Clinical trial NCT00760669 · COMPLETED

Trial details

NCT number: NCT00760669
Sponsor: Janssen Korea, Ltd., Korea
Status: COMPLETED
Study type: OBSERVATIONAL

Spondylitis, Ankylosing Arthritis, Rheumatoid Psoriasis Arthritis, Psoriatic

Start date: 2007-05-01
Primary completion: 2011-04-01
Enrollment: 1061

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.